We only have this paper's title and publication details.
Read it at the sourceRandomized double-blind trial evaluates subcutaneous golimumab outcomes in active polyarticular juvenile idiopathic arthritis, indicating therapeutic potential for pediatric joint inflammation.
NCT01230827; Results.
No takes yet. Share an insight, caveat, or question.
Brunner et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: